Although bradykinin-receptor antagonists and kallikrein inhibitors are now approved therapeutic options for angioneurotic edema [41], suggesting a bradykinin-mediated mechanism, it is noteworthy that published case reports of amlodipine-associated angioedema document resolution primarily with corticosteroids and antihistamines rather than these newer agents. Here, KNG1 is linked to angioedema.